CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Oncology Endocrinology Pediatrics
Current opinions on how to identify and treat NTRK fusion positive cancer
Experts
Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca-
Downloadable
Resources -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
Oncology
NTRK CONNECT provides an overview of the occurrence of NTRK fusions and TRK inhibitor therapy in GI cancer
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Pediatrics Endocrinology
Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer
Experts
Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò-
5 MIN
-
Sep 2021
Endocrinology Pediatrics Oncology
Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
Experts
Dr Luca Toschi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology
Key Publication Snapshot – Detection of NTRK 1/3 rearrangements in Papillary Thyroid Carcinoma
Experts
Prof. Fernando López-Ríos-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology
Key Publication Snapshot 4: Diagnosis and management of NTRK fusion positive sarcomas – recommendations from the World Sarcoma Network
Experts
Dr Tracy L Stockley-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy
Experts
Prof. Ezra Cohen-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK CONNECT Update from ESMO 2019
Experts
Assoc. Prof. Caterina Marchiò-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology
Molecular subtypes in paediatric and adult sarcomas, including CIC-DUX4, NTRK gene fusions and SDH-deficient GIST
Experts
Prof. George Demetri-
Downloadable
Resources -
7 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from ASCO and WCGIC 2021
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Experts
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Assoc. Prof. Gerald Prager-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021
Experts
Dr Fernando Santini-
Downloadable
Resources -
5 MIN
-
Sep 2021
Endocrinology Pediatrics Oncology
Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer
Experts
Prof. Fernando López-Ríos-
Downloadable
Resources -
5 MIN
-
Sep 2021
Interactive e-learning
Oncology Pediatrics
TRK fusion-positive sarcomas and lung cancer e-learning
Experts
Prof. Erin Rudzinski, Prof. Robin Jones, Prof. Christian Rolfo-
Downloadable
Resources -
60 MIN
-
Sep 2021
Pediatrics Oncology
Molecular subtypes that exist in paediatric and adult sarcomas. This includes a spotlight on the potential indicators that may hint at the presence of NTRK gene fusions
Experts
Prof. George Demetri-
Downloadable
Resources -
7 MIN
-
Sep 2021
-
5 MIN
-
Sep 2021
Oncology
An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition
Experts
Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr Shinji Ohno, Dr Rebecca Dent, Prof. Charlie Gourley-
Downloadable
Resources -
60 MIN
-
Sep 2021
Oncology
The Role of PARPi in Prostate Cancer: Experts Knowledge Share
Experts
Prof. Emmanuel S. Antonarakis, Dr Neal D. Shore, Dr Andrew J. Armstrong-
Downloadable
Resources -
5 MIN
-
Sep 2021
Interactive e-learning
Oncology
The Role of PARP Inhibition in Prostate Cancer: e-Learning Now Available
Experts
Prof. Emmanuel S. Antonarakis, Dr Neal D. Shore, Dr Andrew J. Armstrong-
Downloadable
Resources -
60 MIN
-
Sep 2021
Interactive e-learning
Oncology
The Role of PARP Inhibition in Clinical Practice
Experts
Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine-
60 MIN
-
Sep 2021
Oncology
Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy
Experts
Dr Judith Balmaña, Dr Rebecca Dent, Prof. Simon Boulton, Prof. Sibylle Loibl, Prof. Eric Pujade-Lauraine, Prof. Charlie Gourley, Dr Violeta Serra, Prof. Jonathan A. Ledermann-
Downloadable
Resources -
10 MIN
-
Sep 2021
Other
Oncology
The Role of DDR and PARP inhibition (PARPi) in Oncology – BluePrints
Experts
Dr Violeta Serra, Prof. Jonathan A. Ledermann, Prof. Eric Pujade-Lauraine, Prof. Simon Boulton, Dr Mark J. O'Connor, Prof. Charlie Gourley, Dr Judith Balmaña, Prof. Sibylle Loibl-
Downloadable
Resources -
MIN
-
Sep 2021
Video
Oncology
Understand the MoA of PARP inhibitors and targeting DNA Damage Response (DDR)
Experts
Dr Robert L. Coleman, Prof. Simon Boulton-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology
The role and place of genetic testing in prostate cancer
Our GU CONNECT experts provide their thoughts and opinions on the challenging topic of the role and place of genetic testing in prostate cancer.
Experts
Dr Elena Castro, Dr Neal D. Shore, Dr Daniel Keizman, Prof. Gerhardt Attard-
Downloadable
Resources -
5 MIN
-
Sep 2021
Podcast
Oncology
Podcast: TRK fusion-positive GI cancers
Experts
Prof. Frédérique Penault-Llorca, Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
20 MIN
-
Oct 2021
Oncology
PARP inhibition and DNA Damage Response (DDR)
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Experts
Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley-
30 MIN
-
Oct 2021
Oncology Rare diseases Pediatrics
Targeting NTRK gene fusions
Experts
Prof. Fernando López-Ríos, Prof. Andrea Sartore-Bianchi, Assoc. Prof. Gerald Prager, Dr Jaclyn Hechtman-
30 MIN
-
Dec 2021
Podcast
Oncology Pediatrics
Podcast: TRK fusion-positive lung cancer
Experts
Prof. Christian Rolfo, Assoc. Prof. Caterina Marchiò-
Downloadable
Resources -
20 MIN
-
Dec 2021
Oncology
Using immunohistochemistry to detect TRK fusion-positive cancer
Experts
Prof. Frédérique Penault-Llorca-
Downloadable
Resources -
5 MIN
-
May 2022
Rare diseases Oncology
TRK fusion-positive cancer highlights from ASCO 2022
Experts
Prof. David Hong-
Downloadable
Resources -
5 MIN
-
Jun 2022
Interactive e-learning
Module
1
of 3
Oncology
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer
Assoc. Prof. Caterina Marchio: A lung cancer case
Experts
Dr Philipp Ivanyi, Assoc. Prof. Caterina Marchiò, Prof. David Hong-
Downloadable
Resources -
15 MIN
-
Aug 2022
TRK fusion-positive cancer: new ESMO OncologyPRO learning resource
Experts
Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca, Prof. Silvia Stacchiotti, Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Prof. Christian Rolfo-
30 MIN
-
Aug 2022
Oncology
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
Oncology
Update From ESMO 2022 Presidential Sessions
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo-
10 MIN
-
Sep 2022
-
Downloadable
Resources -
5 MIN
-
Sep 2022
Episode
1
of 3
Oncology
TRK fusion-positive cancer poster tour at ESMO 2022
Poster 1: Dufresne A. et al (ESMO 2022)
Experts
Prof. David Hong-
1 MIN
-
Oct 2022
Oncology
Current perspectives on TRK fusion-positive thyroid cancers
Clinical summary video and slides
Experts
Prof. Ezra Cohen-
Downloadable
Resources -
5 MIN
-
Dec 2022
Oncology Hemato-oncology
Update From ASH 2022
Highlights from the ASH Annual Meeting
Experts
Dr Matthew J. Matasar-
4 MIN
-
Dec 2022
Video
Episode
1
of 2
Oncology
The Role of the Nurse in nmCRPC Patient Management
The role of the nurse in nmCRPC patient management
Experts
Pablo PeinadoEndorsed by
-
Downloadable
Resources -
5 MIN
-
Mar 2023
Interactive patient case
Oncology
Diagnosis and Treatment of TRK Fusion-Positive Lung Cancer
How will your clinical decisions impact a patient at two key stages in their journey?
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
May 2023
Conference update
Episode
1
of 6
Oncology
Listen to Expert Insights on Late-Breaking Data from ASCO 2023
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial
Experts
Dr Mansoor Raza Mirza, Dr Paolo Tarantino, Prof. Alexey V Danilov, Prof. Mark Socinski, Prof. Evan Yu, Prof. Thomas Powles, Assoc. Prof. Gerald Prager-
2 MIN
-
Jun 2023
Video
Oncology Pediatrics
Conference Update: ASCO and WCGIC 2023
An expert perspective on the latest data in precision oncology
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Jul 2023
Podcast
Oncology
An Introduction to Molecular Testing
Listen to PRECISION ONCOLOGY CONNECT experts in conversation
Experts
Dr Tracy L Stockley, Prof. David Hong-
Downloadable
Resources -
24 MIN
-
Jul 2023
Conference update
Oncology
Precision Oncology Update From ESMO 2023
How will the latest data impact clinical practice?
Experts
Dr Philipp Ivanyi-
Downloadable
Resources -
3 MIN
-
Oct 2023
Podcast
Episode
1
of 3
Oncology
Prostate cancer: Pre-analytical phase challenges and biomarker testing
Moderated by the Oncology Brothers. Episode 1 of a 3-part video podcast series
Experts
Dr Alexander Wyatt, Dr Petros Grivas, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
30 MIN
-
Nov 2023
Podcast
Oncology
An overview of tumour agnostic therapies
How do they impact clinical practice?
Experts
Prof. David Hong, Dr Tracy L Stockley-
Downloadable
Resources -
22 MIN
-
Dec 2023
Other
Oncology
Lung Cancer – Patient and caregiver survey
Survey into lung cancer biomarker testing and impact on treatment
Experts
Prof. Christian Rolfo, Prof. Fernando López-RíosEndorsed by
-
Downloadable
Resources -
2 MIN
-
Jan 2024
Podcast
Episode
2
of 3
Oncology
Lung Cancer: Pre-analytical phase challenges and biomarker testing
Moderated by the Oncology Brothers. Episode 2 of a 3-part video podcast series
Experts
Dr Bruna Pellini, Dr Semir Vranić, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
27 MIN
-
Jan 2024
Podcast
Episode
3
of 3
Oncology
Ovarian Cancer: Pre-analytical phase challenges and biomarker testing
Moderated by the Oncology Brothers. Episode 2 of a 3-part video podcast series
Experts
Assoc. Prof. Martina Murphy, Assoc. Prof. Caterina Marchiò, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
32 MIN
-
Feb 2024
Podcast
Oncology
Precision oncology approaches in lung cancer
Explore pre-analytical phase challenges and biomarker testing in lung cancer. Moderated by the Oncology Brothers.
Experts
Dr Bruna Pellini, Dr Semir Vranić, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
25 MIN
-
Mar 2024
Other
Oncology
Lung cancer survey: Patient views on biomarker testing
Share the survey with patients with lung cancer and their caregivers
Experts
Prof. Christian Rolfo, Prof. Fernando López-RíosEndorsed by
-
Downloadable
Resources -
2 MIN
-
Mar 2024
Interactive patient case
Oncology
TRK fusion-positive lung cancer: Diagnosis and treatment
Make decisions for your patient at two key stages in their journey
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
Mar 2024
Podcast
Oncology
Perseverance in molecular testing in NSCLC pays off
Looking beyond the obvious mutations in non-small-cell lung cancer
Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski-
Downloadable
Resources -
26 MIN
-
Mar 2024